SpacePharma logo

SpacePharma

SpacePharma, headquartered in Couvet, Switzerland (Neuchâtel canton) and founded in 2012, is a Swiss commercial microgravity research company that miniaturizes laboratory experiments for operation in the space environment — enabling pharmaceutical, biotechnology, crystal growth, and materials science research to be conducted in the microgravity conditions of the International Space Station and small satellites at dramatically lower cost than traditional ISS payload systems.

Couvet, Switzerland Est. 2012 Commercial
Visit Website
Quick Facts
Country
Switzerland
Founded
2012
Type
commercial
Status
operational

About SpacePharma

SpacePharma, headquartered in Couvet, Switzerland (Neuchâtel canton) and founded in 2012, is a Swiss commercial microgravity research company that miniaturizes laboratory experiments for operation in the space environment — enabling pharmaceutical, biotechnology, crystal growth, and materials science research to be conducted in the microgravity conditions of the International Space Station and small satellites at dramatically lower cost than traditional ISS payload systems.

SpacePharma's core technology is the SP-Lab — a miniaturized, automated microfluidic laboratory system small enough to fit within the constraints of a CubeSat deployment or a small ISS experiment volume, yet capable of running controlled multi-step biological and chemical experiments with precise temperature, pH, and reagent control. The SP-Lab's microfluidic chip architecture enables experiments that would require a bench full of laboratory equipment on Earth to run autonomously in orbit with no astronaut intervention, using programmed fluid routing through micro-channels to mix reagents, introduce samples, and perform assays at scheduled mission timeline points.

In microgravity, convection-driven mixing and sedimentation are absent — enabling protein crystallization at larger, more ordered crystal sizes than achievable on Earth (valuable for X-ray crystallography of pharmaceutical targets), cell culture without the gravitational stresses that alter gene expression and morphology, and colloidal aggregation studies for drug formulation. SpacePharma's customers include pharmaceutical companies studying protein structure for drug discovery, biotechnology researchers growing organoids and 3D cell cultures in microgravity, and materials scientists studying solidification and crystal growth phenomena.

SpacePharma has operated experiments on the ISS via Dragon and Cygnus cargo missions, and launched its own SP-Lab-equipped nanosatellites aboard ISRO PSLV rideshare missions, providing low-cost, faster-access alternatives to ISS campaigns for experiments that don't require crew interaction. The company competes with NanoRacks (now Voyager Space), CASIS managed ISS National Laboratory programs, and Axiom Space's research services.

Categories & Capabilities

Industry Categories

Location

Loading map...

Click and drag to explore • Double-click to zoom

Share

Suggest an Edit

Is this information outdated or incorrect? Help us improve this profile.

Submit Correction

Explore More

Discover 1,000+ space companies worldwide

Browse All Companies

Frequently asked about SpacePharma

Quick answers to the questions readers most often search for.

When was SpacePharma founded?
SpacePharma was founded in 2012 in Switzerland.
Where is SpacePharma headquartered?
SpacePharma is headquartered in Couvet, Switzerland.
What does SpacePharma do?
SpacePharma, headquartered in Couvet, Switzerland (Neuchâtel canton) and founded in 2012, is a Swiss commercial microgravity research company that miniaturizes laboratory experiments for operation in the space environment — enabling pharmaceutical, biotechnology, crystal growth, and materials science research to be con…
Is SpacePharma a public or private company?
SpacePharma is currently a private commercial (status: operational).
What sector does SpacePharma operate in?
SpacePharma operates in in-space-services, research.

Data Accuracy Notice: Information about SpacePharma is compiled from publicly available sources including company websites, press releases, regulatory filings, and industry reports. Data is reviewed periodically but may not reflect the most recent developments.

Last updated: June 30, 2026
Company representatives may submit corrections This page does not constitute an endorsement or affiliation Learn about our data methodology